Compound information
- Natural Products
- ZC104203
- Molecular Formula
- C16H25BN2O6S
- Molecular Weight
- 384.15263792 g/mol
- Structure
-
- IUPAC Name
- [5-(4-tert-butoxycarbonylpiperazin-1-yl)sulfonyl-2-methyl-phenyl]boronic acid
- InChI
- InChI=1S/C16H25BN2O6S/c1-12-5-6-13(11-14(12)17(21)22)26(23,24)19-9-7-18(8-10-19)15(20)25-16(2,3)4/h5-6,11,21-22H,7-10H2,1-4H3
- InChI Key
- YFCVHTAAECCKPM-UHFFFAOYSA-N
- SMILES
- Cc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1B(O)O
- Source
- ZINC000520795404
Warheads
- Carbamate
-
- Boronic Acid
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 2 |
Heteroatom Count | 10 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 107.38 Å2 | LogP | 1.794 |
LogS | -3.326 | LogD | 2.743 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.091 | Pgp substrate | 0.026 |
HIA | 0.932 | F20 % | 0.811 |
F30 % | 0.001 | Caco-2 | -4.615 |
MDCK | -5.024 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.921 | PPB | 96.143 |
VD | 1.696 | Fu | 0.838 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.393 |
CYP2A6 substrate | 0.426 | CYP2B6 substrate | 0.558 |
CYP2C19 inhibitor | 0.358 | CYP2C19 substrate | 0.671 |
CYP2C8 substrate | 0.571 | CYP2C9 inhibitor | 0.027 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.094 |
CYP2D6 substrate | 0.712 | CYP2E1 substrate | 0.323 |
CYP3A4 inhibitor | 0.056 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.393 | CL | 7.569 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.149 | Hepatotoxicity | 0.974 |
Mutagenicity | 0.037 | Rat Oral Acute Toxicity | 0.026 |
FDAMDD | 0.035 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.848 | Eye Corrosion | 0.002 |
Eye Irritation | 0.336 | Respiratory Toxicity | 0.084 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.975 | IGC50 | 2.54 |
LC50FM | 3.018 | LC50DM | 0.894 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.152 | NR-AR-LBD | 0.821 |
NR-AhR | 0.065 | NR-Aromatase | 0.976 |
NR-ER | 0.331 | NR-ER-LBD | 0.61 |
NR-PPAR-gamma | 0.821 | SR-ARE | 0.897 |
SR-ATAD5 | 0.844 | SR-HSE | 0.986 |
SR-MMP | 0.024 | SR-p53 | 0.996 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.